AR041717A1 - Granulados de meloxicam solubles en agua - Google Patents
Granulados de meloxicam solubles en aguaInfo
- Publication number
- AR041717A1 AR041717A1 ARP030103888A ARP030103888A AR041717A1 AR 041717 A1 AR041717 A1 AR 041717A1 AR P030103888 A ARP030103888 A AR P030103888A AR P030103888 A ARP030103888 A AR P030103888A AR 041717 A1 AR041717 A1 AR 041717A1
- Authority
- AR
- Argentina
- Prior art keywords
- meloxicam
- water soluble
- eventually
- soluble granulates
- granulates
- Prior art date
Links
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001929 meloxicam Drugs 0.000 title abstract 4
- 239000008187 granular material Substances 0.000 title abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 150000003863 ammonium salts Chemical class 0.000 abstract 1
- 239000011230 binding agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 229960003194 meglumine Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10250081A DE10250081A1 (de) | 2002-10-25 | 2002-10-25 | Wasserlösliche Meloxicam Granulate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041717A1 true AR041717A1 (es) | 2005-05-26 |
Family
ID=32103087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030103888A AR041717A1 (es) | 2002-10-25 | 2003-10-24 | Granulados de meloxicam solubles en agua |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20130005714A1 (https=) |
| EP (1) | EP1558262B1 (https=) |
| JP (2) | JP4856377B2 (https=) |
| KR (1) | KR101152689B1 (https=) |
| CN (1) | CN1708307B (https=) |
| AR (1) | AR041717A1 (https=) |
| AT (1) | ATE381337T1 (https=) |
| AU (1) | AU2003276170B2 (https=) |
| BR (1) | BR0315639A (https=) |
| CA (1) | CA2503396C (https=) |
| CO (1) | CO5570680A2 (https=) |
| CY (1) | CY1107298T1 (https=) |
| DE (2) | DE10250081A1 (https=) |
| DK (1) | DK1558262T3 (https=) |
| ES (1) | ES2298619T3 (https=) |
| HR (1) | HRP20050366B1 (https=) |
| MX (1) | MXPA05004211A (https=) |
| MY (1) | MY136901A (https=) |
| PE (1) | PE20040495A1 (https=) |
| PL (1) | PL212425B1 (https=) |
| PT (1) | PT1558262E (https=) |
| RU (1) | RU2333744C2 (https=) |
| TW (1) | TWI336622B (https=) |
| UA (1) | UA81785C2 (https=) |
| UY (1) | UY28039A1 (https=) |
| WO (1) | WO2004037264A1 (https=) |
| ZA (1) | ZA200502702B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
| US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| EP1568369A1 (en) * | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| DE102004030409A1 (de) * | 2004-06-23 | 2006-01-26 | Boehringer Ingelheim Vetmedica Gmbh | Neue Verwendung von Meloxicam in der Veterinärmedizin |
| CN1680427B (zh) * | 2005-02-01 | 2010-08-11 | 杨喜鸿 | 易于水溶解的匹多莫德复盐及其制备方法 |
| WO2007011349A1 (en) * | 2005-07-15 | 2007-01-25 | Teva Pharmaceutical Industries Ltd. | Novel granulation process and granulate produced therefrom |
| AU2006298895B9 (en) * | 2005-09-30 | 2013-01-24 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical preparation containing meloxicam |
| US7572641B2 (en) | 2005-11-22 | 2009-08-11 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical compositions comprising meloxicam and methods of their preparation |
| US7772255B2 (en) * | 2005-12-13 | 2010-08-10 | Supratek Pharma, Inc. | Method of treating tumors with azaxanthones |
| KR100791160B1 (ko) * | 2006-05-30 | 2008-01-02 | 조선대학교산학협력단 | 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물 |
| JP2010083826A (ja) * | 2008-10-01 | 2010-04-15 | Nihon Generic Co Ltd | オキシカム系化合物を含む固形製剤を製造する方法 |
| TR200809200A1 (tr) * | 2008-12-01 | 2009-12-21 | Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� | Meloksikam içeren farmasötik formülasyonlar |
| MX389960B (es) | 2009-10-12 | 2025-03-20 | Boehringer Ingelheim Vetmedica Gmbh | Recipientes para composiciones que comprenden meloxicam. |
| CA2791805A1 (en) | 2010-03-03 | 2011-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| RU2465892C1 (ru) * | 2011-09-21 | 2012-11-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет (НГУ)" | Способ получения высокодисперсного мелоксикама |
| CN103705479B (zh) * | 2012-09-29 | 2017-11-28 | 瑞普（天津）生物药业有限公司 | 一种宠物用美洛昔康缓释片及其制备方法 |
| RU2559000C1 (ru) * | 2014-02-25 | 2015-08-10 | Вячеслав Михайлович Спиридонов | Кормовая добавка бфк |
| US9526734B2 (en) * | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
| WO2016086114A1 (en) * | 2014-11-25 | 2016-06-02 | Artdem, Llc | Sports drink formulation |
| US20170281640A1 (en) * | 2016-04-04 | 2017-10-05 | Productos Maver, S.A. De C.V. | Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID) |
| EP3541815A4 (en) | 2016-11-18 | 2020-07-15 | Pacira Pharmaceuticals, Inc. | ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME |
| JP2019163249A (ja) * | 2018-03-16 | 2019-09-26 | フジタ製薬株式会社 | メロキシカム水性溶液 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52102416A (en) * | 1976-02-19 | 1977-08-27 | Okawara Mfg | Granule making method of herb medicine and like |
| DE3218150C2 (de) * | 1982-05-14 | 1986-09-25 | Akzo Gmbh, 5600 Wuppertal | Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung |
| JPH0753663B2 (ja) * | 1984-10-09 | 1995-06-07 | 武田薬品工業株式会社 | チアミン塩の顆粒，その製造法および錠剤 |
| IT1207994B (it) * | 1986-01-03 | 1989-06-01 | Therapicon Srl | Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche. |
| US5654003A (en) * | 1992-03-05 | 1997-08-05 | Fuisz Technologies Ltd. | Process and apparatus for making tablets and tablets made therefrom |
| JPH0912426A (ja) * | 1995-06-29 | 1997-01-14 | Asahi Chem Ind Co Ltd | 吸湿性物質組成物 |
| EP0945134A1 (de) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation |
| US6106862A (en) * | 1998-08-13 | 2000-08-22 | Andrx Corporation | Once daily analgesic tablet |
| DE19859636A1 (de) * | 1998-12-23 | 2000-06-29 | Hexal Ag | Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff |
| US6685928B2 (en) * | 1999-12-07 | 2004-02-03 | Rutgers, The State University Of New Jersey | Therapeutic compositions and methods |
| DE10030345A1 (de) * | 2000-06-20 | 2002-01-10 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen |
| WO2001097812A1 (fr) * | 2000-06-20 | 2001-12-27 | Fujisawa Pharmaceutical Co., Ltd. | Preparations pharmaceutiques contenant des composes tetracycliques |
| DE10250081A1 (de) * | 2002-10-25 | 2004-05-13 | Boehringer Ingelheim Vetmedica Gmbh | Wasserlösliche Meloxicam Granulate |
-
2002
- 2002-10-25 DE DE10250081A patent/DE10250081A1/de not_active Withdrawn
-
2003
- 2003-10-23 PE PE2003001075A patent/PE20040495A1/es not_active Application Discontinuation
- 2003-10-24 HR HRP20050366AA patent/HRP20050366B1/hr not_active IP Right Cessation
- 2003-10-24 RU RU2005115955/15A patent/RU2333744C2/ru active
- 2003-10-24 DE DE50308863T patent/DE50308863D1/de not_active Expired - Lifetime
- 2003-10-24 DK DK03809321T patent/DK1558262T3/da active
- 2003-10-24 ES ES03809321T patent/ES2298619T3/es not_active Expired - Lifetime
- 2003-10-24 AR ARP030103888A patent/AR041717A1/es not_active Application Discontinuation
- 2003-10-24 TW TW092129614A patent/TWI336622B/zh not_active IP Right Cessation
- 2003-10-24 PL PL375479A patent/PL212425B1/pl unknown
- 2003-10-24 WO PCT/EP2003/011802 patent/WO2004037264A1/de not_active Ceased
- 2003-10-24 BR BR0315639-7A patent/BR0315639A/pt not_active Application Discontinuation
- 2003-10-24 UA UAA200504878A patent/UA81785C2/uk unknown
- 2003-10-24 EP EP03809321A patent/EP1558262B1/de not_active Expired - Lifetime
- 2003-10-24 MX MXPA05004211A patent/MXPA05004211A/es active IP Right Grant
- 2003-10-24 CA CA2503396A patent/CA2503396C/en not_active Expired - Lifetime
- 2003-10-24 CN CN2003801019791A patent/CN1708307B/zh not_active Expired - Lifetime
- 2003-10-24 AU AU2003276170A patent/AU2003276170B2/en not_active Expired
- 2003-10-24 PT PT03809321T patent/PT1558262E/pt unknown
- 2003-10-24 KR KR1020057006998A patent/KR101152689B1/ko not_active Expired - Lifetime
- 2003-10-24 JP JP2004545974A patent/JP4856377B2/ja not_active Expired - Lifetime
- 2003-10-24 AT AT03809321T patent/ATE381337T1/de active
- 2003-10-24 UY UY28039A patent/UY28039A1/es not_active Application Discontinuation
- 2003-10-25 MY MYPI20034067A patent/MY136901A/en unknown
-
2005
- 2005-04-04 ZA ZA200502702A patent/ZA200502702B/en unknown
- 2005-05-24 CO CO05050509A patent/CO5570680A2/es not_active Application Discontinuation
-
2008
- 2008-03-07 CY CY20081100265T patent/CY1107298T1/el unknown
-
2011
- 2011-06-21 JP JP2011137557A patent/JP5579132B2/ja not_active Expired - Lifetime
-
2012
- 2012-09-05 US US13/604,266 patent/US20130005714A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR041717A1 (es) | Granulados de meloxicam solubles en agua | |
| ECSP056210A (es) | Preparación y uso de derivados de alquilarilo para el tratamiento de la obesidad | |
| SG135192A1 (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| UY27222A1 (es) | Pirazolopirimidinas como agentes terapéuticos | |
| ECSP055669A (es) | Derivados de pirimidinona como agentes terapéuticos contra procesos de remodelación, isquemicos e inflamatorios agudos y cronicos | |
| GT200300034A (es) | Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades | |
| HN2003000063A (es) | Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades. | |
| BRPI0402056A (pt) | Rolo de mascar odontológico, e método de fabricação do mesmo | |
| BRPI0517227B8 (pt) | comprimido oral de liberação prolongada do ácido 1-{[alfa-isobutanoiloxietoxi)carbonil]amino metil}-1-cicloexano acético, e, uso do comprimido | |
| TW200745043A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| BRPI0817275A2 (pt) | Combinação farmacêutica de alisquireno e valsartana | |
| AR042938A1 (es) | Uso del cci-779 en el tratamiento de la fibrosis hepatica | |
| PT2056804E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares | |
| ATE412414T1 (de) | 3,11b-cis-dihydrotetrabenazin zur behandlung von proliferativen krankheiten oder entzündungen | |
| WO2007009720A3 (en) | Prodrugs of pyrazoline compounds, their preparation and use as medicaments | |
| AR058173A1 (es) | Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas | |
| MXPA03001429A (es) | Uso de triazintrion-sulfonas para la lucha contra la coccidiosis. | |
| ITRM20050418A1 (it) | Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina. | |
| ES1051709Y (es) | Fosa para la descomposicion de cadaveres animales. | |
| AR076832A1 (es) | Derivados de 1- amino-alquilciclohexano para el tratamiento de enfermedades inflamatorias de la piel | |
| TW200745042A (en) | Substituted pyrazoline compounds, their preparation and use as medicaments | |
| WO2008144690A3 (en) | Compositions and methods for enhancing active agent absorption | |
| BRPI0412288A (pt) | uso de aivlosina para o tratamento, prevenção ou controle de doenças em virtude de brachyspira pilosicoli em porcos e ornithobacterium rhinotracheale em aves | |
| AR051715A1 (es) | Granulos de principio activo hidrofilo | |
| BRPI0508848A (pt) | uso de pelo menos um composto, sistema iontoforético para a administração de um composto através da pele, cartucho, e, kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |